Deep learning for in vitro prediction of pharmaceutical formulations

被引:1
作者
Yilong Yang [1 ,2 ]
Zhuyifan Ye [1 ]
Yan Su [1 ]
Qianqian Zhao [1 ]
Xiaoshan Li [2 ]
Defang Ouyang [1 ]
机构
[1] State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS),University of Macau
[2] Department of Computer and Information Science, Faculty of Science and Technology, University of Macau
关键词
Pharmaceutical formulation; Deep learning; Small data; Automatic dataset selection algorithm; Oral fast disintegrating films; Oral sustained release matrix tablets;
D O I
暂无
中图分类号
R943 [制剂学];
学科分类号
100602 ; 100702 ;
摘要
Current pharmaceutical formulation development still strongly relies on the traditional trialand-error methods of pharmaceutical scientists. This approach is laborious, time-consuming and costly.Recently, deep learning has been widely applied in many challenging domains because of its important capability of automatic feature extraction. The aim of the present research is to apply deep learning methods to predict pharmaceutical formulations. In this paper, two types of dosage forms were chosen as model systems. Evaluation criteria suitable for pharmaceutics were applied to assess the performance of the models. Moreover, an automatic dataset selection algorithm was developed for selecting the representative data as validation and test datasets. Six machine learning methods were compared with deep learning. Results showed that the accuracies of both two deep neural networks were above 80% and higher than other machine learning models; the latter showed good prediction of pharmaceutical formulations. In summary, deep learning employing an automatic data splitting algorithm and the evaluation criteria suitable for pharmaceutical formulation data was developed for the prediction of pharmaceutical formulations for the first time. The cross-disciplinary integration of pharmaceutics and artificial intelligence may shift the paradigm of pharmaceutical research from experience-dependent studies to data-driven methodologies.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 17 条
[1]  
Predicting oral disintegrating tablet formulations by neural network techniques[J]. Run Han,Yilong Yang,Xiaoshan Li,Defang Ouyang.Asian Journal of Pharmaceutical Sciences. 2018(04)
[2]  
A novel quantified bitterness evaluation model for traditional Chinese herbs based on an animal ethology principle[J]. Xue Han,Hong Jiang,Li Han,Xi Xiong,Yanan He,Chaomei Fu,Runchun Xu,Dingkun Zhang,Junzhi Lin,Ming Yang.Acta Pharmaceutica Sinica B. 2018(02)
[3]   A renaissance of neural networks in drug discovery [J].
Baskin, Igor I. ;
Winkler, David ;
Tetko, Igor V. .
EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (08) :785-795
[4]  
Deep Learning in Drug Discovery[J] . Erik Gawehn,Jan A. Hiss,Gisbert Schneider.Mol. Inf. . 2016 (1)
[5]  
Deep learning in neural networks: An overview[J] . Jürgen Schmidhuber.Neural Networks . 2014
[6]   Fuzzy Logic-Based Expert System for Evaluating Cake Quality of Freeze-Dried Formulations [J].
Trnka, Hjalte ;
Wu, Jian X. ;
Van De Weert, Marco ;
Grohganz, Holger ;
Rantanen, Jukka .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (12) :4364-4374
[7]   Optimization of a doxycycline hydroxypropyl-β-cyclodextrin inclusion complex based on computational modeling [J].
Wang, Zhouhua ;
He, Zixin ;
Zhang, Lei ;
Zhang, Haohao ;
Zhang, Meimei ;
Wen, Xinguo ;
Quan, Guilan ;
Huang, Xintian ;
Pan, Xin ;
Wu, Chuanbin .
ACTA PHARMACEUTICA SINICA B, 2013, 3 (02) :130-139
[8]  
Predicting orally disintegrating tablets formulations of ibuprophen tablets: An application of the new SeDeM-ODT expert system[J] . European Journal of Pharmaceutics and Biopharmaceutics . 2011 (3)
[9]  
Drug design for ever, from hype to hope[J] . G. Seddon,V. Lounnas,R. McGuire,T. den Bergh,R. P. Bywater,L. Oliveira,G. Vriend.Journal of Computer-Aided Molecular Design . 2012 (1)
[10]   Preparation of controlled porosity osmotic pump tablets for salvianolic acid and optimization of the formulation using an artificial neural network method [J].
Xu, Wen-Jin ;
Li, Ning ;
Gao, Chong-kai .
ACTA PHARMACEUTICA SINICA B, 2011, 1 (01) :64-70